Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic drug monitoring in saliva.

× No keyword cloud information.

75 in total

1. Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.

Authors: E S Vesell; G T Passananti; P A Glenwright; B H Dvorchik
Journal: Clin Pharmacol Ther Date: 1975-09 Impact factor: 6.875

2. SOME CELLULAR AND METABOLIC CONSIDERATIONS RELATING TO THE ACTION OF QUINIDINE AS A PROTOTYPE ANTIARRHYTHMIC AGENT.

Authors: H L CONN; R J LUCHI
Journal: Am J Med Date: 1964-11 Impact factor: 4.965

3. The permeability of the human parotid gland to a series of sulfonamide compounds, para-aminohippurate and inulin.

Authors: S A KILLMANN; J H THAYSEN
Journal: Scand J Clin Lab Invest Date: 1955 Impact factor: 1.713

4. Digoxin concentrations in serum and saliva: relationship to ECG changes and dosage in healthy volunteers.

Authors: P H Joubert; B N Aucamp; F O Müller
Journal: Br J Clin Pharmacol Date: 1976-12 Impact factor: 4.335

5. Pharmacokinetics of tolbutamide: prediction by concentration in saliva.

Authors: S B Matin; S H Wan; J H Karam
Journal: Clin Pharmacol Ther Date: 1974-12 Impact factor: 6.875

6. Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.

Authors: I Odar-Cederlöf; O Borgå
Journal: Eur J Clin Pharmacol Date: 1974 Impact factor: 2.953

7. GLC determination of theophylline in biological fluids.

Authors: V P Shah; S Riegelman
Journal: J Pharm Sci Date: 1974-08 Impact factor: 3.534

8. A model for the movement of salicylate across the parotid epithelium.

Authors: J F Borzelleca; J W Putney
Journal: J Pharmacol Exp Ther Date: 1970-09 Impact factor: 4.030

9. Dialysis of ephedrine and pentobarbital from whole human saliva and simulated saliva.

Authors: R E Davis; C W Hartman; J H Fincher
Journal: J Pharm Sci Date: 1971-03 Impact factor: 3.534

10. Salivary excretion of paracetamol in man.

Authors: J P Glynn; W Bastain
Journal: J Pharm Pharmacol Date: 1973-05 Impact factor: 3.765

51 in total

Review 1. Review: therapeutic drug monitoring in pediatrics.

Authors: Offie Porat Soldin; Steven J Soldin
Journal: Ther Drug Monit Date: 2002-02 Impact factor: 3.681

Review 2. Therapeutic drug monitoring in saliva. An update.

Authors: R K Drobitch; C K Svensson
Journal: Clin Pharmacokinet Date: 1992-11 Impact factor: 6.447

Review 3. Therapeutic drug monitoring of phenytoin. Rationale and current status.

Authors: M Levine; T Chang
Journal: Clin Pharmacokinet Date: 1990-11 Impact factor: 6.447

4. A comparison of serum and saliva paracetamol concentrations.

Authors: M Smith; E Whitehead; G O'Sullivan; F Reynolds
Journal: Br J Clin Pharmacol Date: 1991-05 Impact factor: 4.335

Review 5. Drug monitoring in nonconventional biological fluids and matrices.

Authors: S Pichini; I Altieri; P Zuccaro; R Pacifici
Journal: Clin Pharmacokinet Date: 1996-03 Impact factor: 6.447

6. Ethical considerations in the conduct of clinical pharmacokinetic studies.

Authors: C K Svensson
Journal: Clin Pharmacokinet Date: 1989-10 Impact factor: 6.447

7. Plasma and salivary pharmacokinetics of dapsone estimated by a thin layer chromatographic method.

Authors: R A Ahmad; H J Rogers
Journal: Eur J Clin Pharmacol Date: 1980-02 Impact factor: 2.953

8. Influence of local radiotherapy on penetration of fluconazole into human saliva.

Authors: J Oliary; M Tod; K Louchahi; O Petitjean; B Frachet; V Le Gros; N Brion
Journal: Antimicrob Agents Chemother Date: 1993-12 Impact factor: 5.191

9. Recent advances in drug therapy for epilepsy.

Authors: J Bruni
Journal: Can Med Assoc J Date: 1979-04-07 Impact factor: 8.262

10. Lack of correlation between methotrexate concentrations in serum, saliva and sweat after 24 h methotrexate infusions.

Authors: H Schrøder; K B Jensen; M Brandsborg
Journal: Br J Clin Pharmacol Date: 1987-10 Impact factor: 4.335